The post Franklin Templeton’s XRP ETF receives NYSE listing approval appeared on BitcoinEthereumNews.com. Key Takeaways Franklin Templeton’s XRP ETF has secured approval for listing on NYSE Arca. The fund will trade under XRPZ and feature a 0.19% NAV-based sponsor fee. NYSE Arca has approved the listing of Franklin Templeton’s XRP ETF and formally certified the action to the SEC. It means the fund has met all exchange requirements and is nearing launch. Per Franklin’s latest disclosure, the ETF, the Franklin XRP Trust, will list under the ticker XRPZ and impose an annual sponsor fee of 0.19% of net asset value. The sponsor plans to waive the fee entirely on the initial $5 billion in assets through May 31, 2026. Franklin will soon join a number of fund managers in bringing a regulated investment product tied to XRP to the US market. Canary Capital and Bitwise Asset Management rolled out their spot XRP ETFs earlier this month. Grayscale is poised to launch its spot XRP and Dogecoin ETFs tomorrow after securing final clearance. XRP was trading at over $2 at press time, up almost 3% in the last 24 hours, CoinGecko data shows. Source: https://cryptobriefing.com/franklin-templeton-xrp-etf-receives-nyse-listing-approval/The post Franklin Templeton’s XRP ETF receives NYSE listing approval appeared on BitcoinEthereumNews.com. Key Takeaways Franklin Templeton’s XRP ETF has secured approval for listing on NYSE Arca. The fund will trade under XRPZ and feature a 0.19% NAV-based sponsor fee. NYSE Arca has approved the listing of Franklin Templeton’s XRP ETF and formally certified the action to the SEC. It means the fund has met all exchange requirements and is nearing launch. Per Franklin’s latest disclosure, the ETF, the Franklin XRP Trust, will list under the ticker XRPZ and impose an annual sponsor fee of 0.19% of net asset value. The sponsor plans to waive the fee entirely on the initial $5 billion in assets through May 31, 2026. Franklin will soon join a number of fund managers in bringing a regulated investment product tied to XRP to the US market. Canary Capital and Bitwise Asset Management rolled out their spot XRP ETFs earlier this month. Grayscale is poised to launch its spot XRP and Dogecoin ETFs tomorrow after securing final clearance. XRP was trading at over $2 at press time, up almost 3% in the last 24 hours, CoinGecko data shows. Source: https://cryptobriefing.com/franklin-templeton-xrp-etf-receives-nyse-listing-approval/

Franklin Templeton’s XRP ETF receives NYSE listing approval

2025/11/24 11:52

Key Takeaways

  • Franklin Templeton’s XRP ETF has secured approval for listing on NYSE Arca.
  • The fund will trade under XRPZ and feature a 0.19% NAV-based sponsor fee.

NYSE Arca has approved the listing of Franklin Templeton’s XRP ETF and formally certified the action to the SEC. It means the fund has met all exchange requirements and is nearing launch.

Per Franklin’s latest disclosure, the ETF, the Franklin XRP Trust, will list under the ticker XRPZ and impose an annual sponsor fee of 0.19% of net asset value. The sponsor plans to waive the fee entirely on the initial $5 billion in assets through May 31, 2026.

Franklin will soon join a number of fund managers in bringing a regulated investment product tied to XRP to the US market. Canary Capital and Bitwise Asset Management rolled out their spot XRP ETFs earlier this month.

Grayscale is poised to launch its spot XRP and Dogecoin ETFs tomorrow after securing final clearance.

XRP was trading at over $2 at press time, up almost 3% in the last 24 hours, CoinGecko data shows.

Source: https://cryptobriefing.com/franklin-templeton-xrp-etf-receives-nyse-listing-approval/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.